Patient Stratification An important factor in modern clinical trials relating to pharmacogenetic medicines is the ability to delineate responders from non-responders along a consistent and predictable line. Through our FDA GLP level DNA Sequencing, qPCR, and Microarray (SNP Genotyping and Expression Analysis) services, SeqWright can help you generate responder-specific data via sequence and expression-based stratification of your trial population. |
||
Related Services |
||
| Recent Experience: |